HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

Innovative Industrial Properties

Houston, cannabis stocks have a financing problem.

Marijuana Stocks Have Serious Cash Concerns

The terms of a new stock offering aren't making investors happy.

Why HEXO Shares Are Crashing Today

Aurora Cannabis

Aphria

Canopy Growth

Cronos Group

Tilray Brands

Cannabis stocks had a huge showing on Wall Street last year. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Yield on Cannabis Stocks

U.S.-listed shares of Canadian cannabis company Hexo Corp. HEXO, +2.62% HEXO, +2.39% slid 13% in premarket trade Thursday, after the company announced a $25 million registered direct share offering.

Canadian cannabis company Hexo shares slide 13% premarket after news of $25 million stock offering

OTTAWA, Dec.  26, 2019  (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced it has entered into a definitive agreement with institutional investors for the purchase and sale of 14,970,062 common shares at an offering price of US$1.67 per share for gross proceeds of US$25.0 million before deducting fees and other estimated offering expenses, pursuant to a registered direct offering (the “Offering”). The Company has also agreed to issue to the investors common share purchase warrants to purchase 7,485,032 common shares of the Company. The warrants will have a five year-term and an exercise price of US$2.45 per share.

HEXO Corp. Announces US$25.0 Million Registered Direct Offering

With Cannabis 2.0 in the works, Hexo’s risk-reward profile is beginning to look very favorable for investors willing to stick their necks out. Here’s why.

Hexo Hoping to Recover With Cannabis 2.0 Boom in 2020

There are still many red flags surrounding the company.

These 3 Numbers From HEXO's Q1 Should Concern Cannabis Investors

These five stocks should profit significantly from the new multibillion-dollar opportunity.

Which Marijuana Stocks Will Be the Biggest Winners in Canada's Cannabis 2.0 Market?

CannTrust Holdings

The green rush was a veritable trash fire this year.

10 Reasons Marijuana Stocks Were Pummeled in 2019

Canada's most populous province is getting aggressive after being overwhelmed by black market marijuana producers.

At Long Last, Ontario Is Shelving Its Cannabis Lottery System for Dispensaries

Forget talk of capacity expansion! Marijuana stocks are reducing output at a staggering pace.

5 Cannabis Stocks Cutting Their 2020 Production

This pot stock continues to lose money. What should investors do?

HEXO Continues to Hemorrhage Cash: First-Quarter Losses Up 487%

Cash burn will result in equity dilution. Slower growth likely in medicinal and recreational cannabis due to regulatory headwinds.

It Doesn’t Look as If 2020 Will Be Any Better for Hexo Stock

Hexo Corp (NYSE: HEXO) shares traded lower by 2.9% on Monday after the company’s fiscal first-quarter earnings came up short of market expectations.

Analyst On Hexo Earnings: 'We Had Expected Worse'

Some issues for the Canadian cannabis producer weren't as obvious as others.

3 Problems You Might Not Have Noticed in HEXO's Q1 Results

The cannabis company's top line came in below analyst expectations.

HEXO Q1 Net Revenue Falls, and Its Loss Deepens

HEXO Corp. (HEXO) CEO Sebastien St-Louis on Fiscal Q1 2020 Results - Earnings Call Transcript

HEXO Corp. (HEXO) CEO Sebastien St-Louis on Q1 2020 Results - Earnings Call Transcript

HEXO Corp. (TSX: HEXO) (NYSE: HEXO) reported first-quarter net revenue of CA$14.5 million ($11.05 million) Monday, down from CA$15.4 million in the previous quarter and CA$5.7 million one year ago.

Hexo Posts Q1 Net Loss of CA$62.4 Million, Lower OpEx

Hexo Corp. HEXO, +0.45% reported Monday a fiscal first-quarter loss that widened nearly 5-fold from a year ago as net revenue more than doubled but revenue per gram declined.

Hexo's stock falls after net loss widens nearly 5-fold

It’s been a brutal year for cannabis stocks, and Hexo Corp (NYSE: HEXO) is no exception.

Hexo's Q1 Report Could Be Ugly, Says Cantor Fitzgerald

Hexo has significant growth and balance sheet problems. A strong Q1 report won't fix those issues, but could inspire confidence in a turnaround.

Earnings Will Be Critical for Hexo Stock

At the end of the day, the cannabis industry will birth only 5 to 10 big winners, and HEXO stock likely won't be one of them. 
The post Why Investors Should Continue to Say No to Hexo Stock appeared first on InvestorPlace.

Why Investors Should Continue to Say No to Hexo Stock

In the latest trading session, HEXO (HEXO) closed at $2.19, marking no change from the previous day.

HEXO (HEXO) Flat As Market Gains: What You Should Know

I'm still bullish on marijuana stocks, but I won't let Hexo stock weigh down my portfolio.
The post Hexo?

News for HEXO Corp Stock (HEXO)